Literature DB >> 12696063

Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events.

Silvana Debernardi1, Debra M Lillington, Tracy Chaplin, Simon Tomlinson, John Amess, Ama Rohatiner, T Andrew Lister, Bryan D Young.   

Abstract

Gene expression profiles were determined from presentation peripheral blood and bone marrow samples of 28 patients with acute myeloid leukemia (AML). Hierarchical clustering sorted the profiles into separate groups, each representing one of the major cytogenetic classes in AML [i.e., t(8;21), t(15;17), inv(16), 11q23, and normal karyotype]. Statistical group comparison identified genes whose expression was strongly correlated with these chromosomal classes. Moreover, the normal karyotype AMLs were characterized by distinctive up-regulation of certain members of the class I homeobox A and B gene families, implying a common underlying genetic lesion. These data reveal novel diagnostic and therapeutic targets and demonstrate the potential of microarray-based dissection of AML. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12696063     DOI: 10.1002/gcc.10198

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  33 in total

1.  Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.

Authors:  Sanggyu Lee; Jianjun Chen; Guolin Zhou; Run Zhang Shi; Gerard G Bouffard; Masha Kocherginsky; Xijin Ge; Miao Sun; Nimanthi Jayathilaka; Yeong Cheol Kim; Neelmini Emmanuel; Stefan K Bohlander; Mark Minden; Justin Kline; Ozden Ozer; Richard A Larson; Michelle M LeBeau; Eric D Green; Jeffery Trent; Theodore Karrison; Piu Paul Liu; San Ming Wang; Janet D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

2.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.

Authors:  Roel G W Verhaak; Bas J Wouters; Claudia A J Erpelinck; Saman Abbas; H Berna Beverloo; Sanne Lugthart; Bob Löwenberg; Ruud Delwel; Peter J M Valk
Journal:  Haematologica       Date:  2008-10-06       Impact factor: 9.941

Review 3.  Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies.

Authors:  Luiza Handschuh
Journal:  J Oncol       Date:  2019-07-30       Impact factor: 4.375

Review 4.  Molecular cytogenetics in haematological malignancy: current technology and future prospects.

Authors:  Lyndal Kearney; Sharon W Horsley
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

5.  HOX expression patterns identify a common signature for favorable AML.

Authors:  M Andreeff; V Ruvolo; S Gadgil; C Zeng; K Coombes; W Chen; S Kornblau; A E Barón; H A Drabkin
Journal:  Leukemia       Date:  2008-07-31       Impact factor: 11.528

6.  HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy.

Authors:  Glenda J Dickson; Fabio G Liberante; Laura M Kettyle; Kathleen A O'Hagan; Damian P J Finnegan; Lars Bullinger; Dirk Geerts; Mary Frances McMullin; Terry R J Lappin; Ken I Mills; Alexander Thompson
Journal:  Haematologica       Date:  2013-03-28       Impact factor: 9.941

Review 7.  Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics.

Authors:  Tara K Gregory; David Wald; Yichu Chen; Johanna M Vermaat; Yin Xiong; William Tse
Journal:  J Hematol Oncol       Date:  2009-06-02       Impact factor: 17.388

8.  POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature.

Authors:  J M Fortier; J E Payton; P Cahan; T J Ley; M J Walter; T A Graubert
Journal:  Leukemia       Date:  2010-04-08       Impact factor: 11.528

9.  Integrative meta-analysis of differential gene expression in acute myeloid leukemia.

Authors:  Brady G Miller; John A Stamatoyannopoulos
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

10.  In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: early gene expression profiling reveals possible drug target in AML.

Authors:  Anmaar M Abdul-Nabi; Enas R Yassin; Nobish Varghese; Hrishikesh Deshmukh; Nabeel R Yaseen
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.